Advanced search×

[Improving the effectiveness of functional jaw orthopedics in Class II malocclusion by appropriate treatment timing].

Orthod Fr 81(4):279-86 (2010) PMID 21144469

Time can be considered the fourth dimension in dento-facial orthopedics. Treatment timing can play a significant role in the outcomes of treatment aimed to produce an orthopedic effect in the craniofacial structures. The results of methodologically-sound cephalometric studies of both the past and the recent history of orthodontics clearly indicate that optimal treatment timing for Class II skeletal disharmony with a functional appliance (e.g. twin block) is during or slightly after the peak in mandibular growth as revealed by a reliable biologic indicator of individual skeletal maturity such as the cervical vertebral maturation method.

DOI: 10.1051/orthodfr/2010026
Version: za2963e q8za4 q8zbc q8zce q8zdf q8ze1 q8zf1 q8zg7

Similar articles you may find interesting…

  1. Human urine-derived stem cells seeded in a modified 3D porous small intestinal submucosa scaffold for urethral tissue engineering

    Biomaterials 32(5):10 (2011) PMID 21055807

    The goal of this study was to determine whether urothelial cells (UC) and smooth muscle cells (SMC) derived from the differentiation of urine-derived stem cells (USC) could be used to form engineered urethral tissue when seeded on a modified 3-D porous small intestinal submucosa (SIS...
  2. Optimizing sedation and analgesia in mechanically ventilated patients--an evidence-based approach.

    Dynamics 14(4):10-3 (2003) PMID 15453566

    Critically ill, mechanically ventilated patients experience pain and anxiety related to a number of factors, including underlying disease processes, invasive procedures, therapeutic devices, immobility, and even routine nursing care such as turning and positioning. Failure to provide adequate analge...
  3. Intensified surveillance after surgery for colorectal cancer significantly improves survival.

    European Journal of Medical Research 15(1):25-30 (2010) PMID 20159668 PMCID PMC3351844

    Out of 1469 patients 858 patients underwent "intensive", 297 "minimal" and 314 "none" surveillance. The three groups were well balanced regarding biographical data and tumor characteristics. The 5-year survival rates were 79% (intensive), 76% (minimal) and 54% (none) (OR 1.480, (95% CI 1.135-1.929);...